{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:59:42Z","timestamp":1785599982371,"version":"3.56.0"},"reference-count":177,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jceh.2025.103194","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T06:56:36Z","timestamp":1759215396000},"page":"103194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Future Management of Sepsis in Liver Cirrhosis"],"prefix":"10.1016","volume":"16","author":[{"given":"Ayush","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srajit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0110-5982","authenticated-orcid":false,"given":"Rakhi","family":"Maiwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2025.103194_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100719","article-title":"Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany","volume":"27","author":"Kremer","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib2","first-page":"32","article-title":"Bacterial infections in cirrhotic patients in a tertiary care hospital","volume":"9","author":"Lingiah","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12876-021-01871-w","article-title":"Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany","volume":"21","author":"Hillert","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103194_bib4","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1056\/NEJMra2021808","article-title":"The evolving challenge of infections in cirrhosis","volume":"384","author":"Bajaj","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib5","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2147\/IDR.S283723","article-title":"Treatment of hospital-acquired infections in patients with cirrhosis \u2013 new challenges","volume":"15","author":"Maindad","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jceh.2025.103194_bib6","article-title":"Predictors and outcomes of infections in ICU patients with cirrhosis: a single-center observational study","volume":"15","author":"Kulkarni","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jceh.2025.103194_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000038","article-title":"The impact of multidrug-resistant microorganisms on critically ill patients with cirrhosis in the intensive care unit: a cohort study","volume":"7","author":"Kim","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2025.103194_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic-liver-failure in Europe","volume":"70","author":"Fern\u00e1ndez","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib9","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2025.103194_bib10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2022.03.043","article-title":"A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension (ALPS trial)","volume":"77","author":"Maiwall","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12664-024-01536-y","article-title":"Respiratory tract viral infections-associated sepsis in patients with underlying liver disease: viral sepsis \u2014 an entity to look forward","volume":"43","author":"Gupta","year":"2024","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103194_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cmi.2020.04.030","article-title":"Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case\u2013control\u2013control study","volume":"27","author":"Bartoletti","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jceh.2025.103194_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jceh.2025.103194_bib14","unstructured":"American Association for the Study of Liver Diseases. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the AASLD. Hepatology. [Internet]. [cited 2025 Feb 16]. Available from: https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/epdf\/10.1002\/hep.31884."},{"key":"10.1016\/j.jceh.2025.103194_bib15","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. [Internet]. [cited 2025 Feb 16]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168827818319664."},{"key":"10.1016\/j.jceh.2025.103194_bib16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jceh.2025.103194_bib17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/HEP.0000000000000653","article-title":"Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections\u2014Results from the ICA \u201cGlobal Study\u201d (EABCIR-Global Study)","volume":"79","author":"Maiwall","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103194_bib18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.dld.2022.05.011","article-title":"The threat of carbapenem resistance in Eastern Europe in patients with decompensated cirrhosis admitted to intensive care unit","volume":"54","author":"Fischer","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2025.103194_bib19","doi-asserted-by":"crossref","first-page":"7530","DOI":"10.12998\/wjcc.v11.i31.7530","article-title":"Antibiotic resistance in patients with liver cirrhosis: prevalence and current approach to tackle","volume":"11","author":"Liakina","year":"2023","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jceh.2025.103194_bib20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jceh.2022.04.016","article-title":"Ceftazidime-avibactam for the treatment of carbapenem-resistant Klebsiella pneumoniae infections in patients with liver cirrhosis","volume":"12","author":"Feldman","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib21","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1111\/liv.16063","article-title":"Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis","volume":"44","author":"Marciano","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103194_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/CCM.0b013e3181feeb15","article-title":"Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality","volume":"39","author":"Boyd","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4254\/wjh.v12.i8.451","article-title":"Update on diagnosis and management of sepsis in cirrhosis: current advances","volume":"12","author":"Philips","year":"2020","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib24","unstructured":"Singer Mervyn, Deutschman Clifford, Seymour C. Warren, Shankar-Hari M. Djillali Annane, Michael Bauer et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA [Internet]. [cited 2025 Feb 22]."},{"key":"10.1016\/j.jceh.2025.103194_bib25","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatol Baltim Md"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2025.103194_bib26","article-title":"Association of central venous pressure with intra-abdominal pressure, mean airway pressure and hemodynamics: an observational study","volume":"3","author":"Huber","year":"2015","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.jceh.2025.103194_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5847\/wjem.j.issn.1920-8642.2012.03.006","article-title":"Passive leg raising as an indicator of fluid responsiveness in patients with severe sepsis","volume":"3","author":"Dong","year":"2012","journal-title":"World J Emerg Med"},{"key":"10.1016\/j.jceh.2025.103194_bib28","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/CCM.0000000000006399","article-title":"The impact of point-of-care ultrasound-guided resuscitation on clinical outcomes in patients with shock: a systematic review and meta-analysis","volume":"52","author":"Basmaji","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib29","unstructured":"Ahmed Mukhtar, Maha Awad, Mohamed Elayashy, Amr Hussein Gihan Obayah, Akram El Adawy et al. Validity of mini-fluid challenge for predicting fluid responsiveness following liver transplantation. BMC Anesthesiol. [Internet]. [cited 2025 Feb 23]. Available from: https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-019-0728-4."},{"key":"10.1016\/j.jceh.2025.103194_bib30","unstructured":"Anton Krige, Martin Bland, Thomas Fanshawe. Fluid responsiveness prediction using Vigileo FloTrac measured cardiac output changes during passive leg raise test. J Intensive Care [Internet]. [cited 2025 Feb 23]."},{"key":"10.1016\/j.jceh.2025.103194_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2014.10.012","article-title":"Exploration of skin perfusion in cirrhotic patients with septic shock","volume":"62","author":"Galbois","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13613-020-00767-4","article-title":"Effects of capillary refill time- vs. lactate-targeted fluid resuscitation on regional, microcirculatory and hypoxia-related perfusion parameters in septic shock: a randomized controlled trial","volume":"10","author":"Castro","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jceh.2025.103194_bib33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jcrc.2020.08.022","article-title":"Core-to-skin temperature gradient measured by thermography predicts day-8 mortality in septic shock: a prospective observational study","volume":"60","author":"Amson","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.jceh.2025.103194_bib34","unstructured":"Bryant H. Nguyen, Emanuel P. Rivers, Bernhard P. Knoblich, Gordon Jacobsen, Alexandria Muzzin, Julie A. Ressler, et al. Early lactate clearance is associated with improved outcome. Crit Care Med [Internet]. [cited 2025 Feb 23]."},{"key":"10.1016\/j.jceh.2025.103194_bib35","unstructured":"Nozomi Takahashi, Taka-aki Nakada, Keith R. Walley, James A. Russell. Significance of lactate clearance in septic shock patients with high bilirubin levels. Sci Rep [Internet]. [cited 2025 Feb 23]."},{"key":"10.1016\/j.jceh.2025.103194_bib36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hep.30151","article-title":"Lactate improves prediction of short-term mortality in critically ill patients with cirrhosis: a multinational study","volume":"69","author":"Drolz","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103194_bib37","unstructured":"Guclu Aykut, Gerke Veenstra, Claudia Scorcella, Can Ince, Christiaan Boerma. Cytocam-IDF (incident dark field illumination) imaging for bedside monitoring of the microcirculation. Intensive Care Med Exp [Internet]. [cited 2025 Feb 5]."},{"key":"10.1016\/j.jceh.2025.103194_bib38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00134-023-07098-5","article-title":"Direct assessment of microcirculation in shock: a randomized-controlled multicenter study","volume":"49","author":"Bruno","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/j.1478-3231.2009.02157.x","article-title":"A study of muscle tissue oxygenation and peripheral microcirculatory dysfunction in cirrhosis using near infrared spectroscopy","author":"Thomson","year":"2010","journal-title":"Liver Int [Internet]"},{"key":"10.1016\/j.jceh.2025.103194_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03922-4","article-title":"Bedside determination of microcirculatory oxygen delivery and uptake: a prospective observational clinical study for proof of principle","volume":"11","author":"Sturm","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2025.103194_bib41","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib42","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","article-title":"Goal-directed resuscitation for patients with early septic shock","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib43","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A randomized trial of protocol-based care for early septic shock","volume":"370","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib44","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of early, goal-directed resuscitation for septic shock","volume":"372","author":"Mouncey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib45","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","article-title":"Restriction of intravenous fluid in ICU patients with septic shock","volume":"386","author":"Meyhoff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib46","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Lung, and blood institute prevention and early treatment of acute lung injury clinical trials network. Early restrictive or liberal fluid management for sepsis-induced hypotension","volume":"388","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib47","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/CCM.0000000000004617","article-title":"Fluid overload and mortality in adult critical care patients\u2014A systematic review and meta-analysis of observational studies","volume":"48","author":"Messmer","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00134-017-4832-y","article-title":"Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017","volume":"43","author":"Joannidis","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib49","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib50","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114464","article-title":"Balanced multielectrolyte solution versus saline in critically ill adults","author":"Finfer","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib51","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib52","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12072-021-10164-z","article-title":"Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis-induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial","volume":"15","author":"Philips","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.103194_bib53","doi-asserted-by":"crossref","first-page":"H1011","DOI":"10.1152\/ajpheart.00829.2013","article-title":"Albumin modulates S1P delivery from red blood cells in perfused microvessels: mechanism of the protein effect","volume":"306","author":"Adamson","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jceh.2025.103194_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211053313","article-title":"Therapeutic plasma exchange protects patients with sepsis-associated disseminated intravascular coagulation by improving endothelial function","volume":"27","author":"Weng","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jceh.2025.103194_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13054-020-2799-5","article-title":"Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock","volume":"24","author":"Stahl","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jceh.2025.103194_bib56","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jcrc.2013.04.010","article-title":"Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study","volume":"28","author":"Ostrowski","year":"2013","journal-title":"J Crit Care"},{"key":"10.1016\/j.jceh.2025.103194_bib57","unstructured":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis [Internet]. [cited 2025 Feb 23]. Available from: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2770279."},{"key":"10.1016\/j.jceh.2025.103194_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2018.09.042","article-title":"Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis","volume":"171","author":"Iba","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jceh.2025.103194_bib59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.jvca.2010.09.018","article-title":"Vasopressin deficiency and vasodilatory state in end-stage liver disease","volume":"25","author":"Wagener","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jceh.2025.103194_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12871-020-00965-4","article-title":"Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.jceh.2025.103194_bib61","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/liv.13252","article-title":"A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock","volume":"37","author":"Choudhury","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103194_bib62","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/SHK.0000000000002204","article-title":"Terlipressin combined with norepinephrine in the treatment of septic SHOCK: a systematic review","volume":"60","author":"Mao","year":"2023","journal-title":"Shock Augusta Ga"},{"key":"10.1016\/j.jceh.2025.103194_bib63","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1503\/cmaj.090707","article-title":"Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial","volume":"182","author":"Arabi","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.jceh.2025.103194_bib64","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/hep.21352","article-title":"Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival","volume":"44","author":"Fern\u00e1ndez","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2025.103194_bib65","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/1089253219877876","article-title":"Angiotensin II in decompensated cirrhosis complicated by septic shock","volume":"24","author":"Coleman","year":"2020","journal-title":"Semin CardioThorac Vasc Anesth"},{"key":"10.1016\/j.jceh.2025.103194_bib66","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12871-024-02714-3","article-title":"The role of esmolol in sepsis: a meta-analysis based on randomized controlled trials","volume":"24","author":"Wei","year":"2024","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.jceh.2025.103194_bib67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7861\/clinmedicine.18-2-146","article-title":"Diagnosis and management of sepsis","volume":"18","author":"Evans","year":"2018","journal-title":"Clin Med"},{"key":"10.1016\/j.jceh.2025.103194_bib68","doi-asserted-by":"crossref","first-page":"527","DOI":"10.21037\/atm.2016.12.53","article-title":"Scoring systems for the characterization of sepsis and associated outcomes","volume":"4","author":"McLymont","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jceh.2025.103194_bib69","doi-asserted-by":"crossref","unstructured":"Nandakumar Mohan, Samir Shah, Atif Nehvi, Edward Bley, Kevin Bryan Lo, Sarah Perloff, Is the SIRS criteria a good predictor of blood stream infection in cirrhosis? A single-center retrospective analysis, American Journal of Medicine Open, Volume 10, 100052.","DOI":"10.1016\/j.ajmo.2023.100052"},{"key":"10.1016\/j.jceh.2025.103194_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5581587","article-title":"Systemic inflammatory response syndrome in patients hospitalized for acute decompensation of cirrhosis","author":"Borgonovo","year":"2021","journal-title":"Canadian journal of gastroenterology & hepatology"},{"key":"10.1016\/j.jceh.2025.103194_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s43066-023-00245-z","article-title":"Validation of the diagnostic accuracy of neutrophil to lymphocyte ratio (NLR) and mean platelet volume (MPV) in cirrhotic patients with spontaneous bacterial peritonitis","volume":"13","author":"Abudeif","year":"2023","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.jceh.2025.103194_bib72","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s12072-014-9540-x","article-title":"Procalcitonin as a marker of sepsis in alcoholic hepatitis","volume":"8","author":"Kumar","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2025.103194_bib73","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2025.103194_bib74","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004270","article-title":"Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease","volume":"95","author":"Qu","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2025.103194_bib75","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1665-2681(19)31344-4","article-title":"Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis","volume":"12","author":"Lazzarotto","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib76","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/00365520600842195","article-title":"Serum C-reactive protein: a non-invasive marker of alcoholic hepatitis","volume":"41","author":"Vanbiervliet","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103194_bib77","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2011.12.030","article-title":"C-reactive protein predicts short-term mortality in patients with cirrhosis","volume":"56","author":"Cervoni","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib78","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005127","article-title":"Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients: a meta-analysis","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2025.103194_bib79","article-title":"Diagnostic performance of serum galactomannan and \u03b2-D-glucan for invasive aspergillosis in suspected patients: a meta-analysis","volume":"103","author":"Huang","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.jceh.2025.103194_bib80","article-title":"Fungal infections in liver cirrhosis","volume":"9","author":"Iqbal","year":"2024","journal-title":"Transl Gastroenterol Hepatol [Internet]"},{"key":"10.1016\/j.jceh.2025.103194_bib81","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13613-017-0316-z","article-title":"Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis","volume":"7","author":"Wu","year":"2017","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jceh.2025.103194_bib82","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3390\/diagnostics12092077","article-title":"The role of presepsin in diagnosing infections in patients with liver cirrhosis and overt hepatic encephalopathy","volume":"12","author":"Igna","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jceh.2025.103194_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.11.009","article-title":"Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality","volume":"45","author":"Tornai","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jceh.2025.103194_bib84","unstructured":"Circular RNAs in sepsis: biogenesis, Function, and Clinical Significance [Internet]. [cited 2025 Feb 26]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7349763\/#sec4-cells-09-01544."},{"key":"10.1016\/j.jceh.2025.103194_bib85","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2019\/41623.12977","article-title":"Diagnostic utility of real time multiplex PCR for identification of atypical bacterial respiratory pathogens","author":"Batra","year":"2019","journal-title":"J Clin Diagn Res [Internet]"},{"key":"10.1016\/j.jceh.2025.103194_bib86","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1478-3231.2009.02073.x","article-title":"Identification of bacterial DNA in neutrocytic and non-neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction","volume":"29","author":"Bruns","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103194_bib87","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/liv.13095","article-title":"The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection","volume":"36","author":"Bruns","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103194_bib88","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12879-024-09396-9","article-title":"Application of metagenomic next-generation sequencing in optimizing the diagnosis of ascitic infection in patients with liver cirrhosis","volume":"24","author":"Shi","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jceh.2025.103194_bib89","unstructured":"Wei Guo, Xiaojian Cui, Quishi Wang, Yupeng Wei, Yanqing quo et al. Clinical evaluation of metagenomic next-generation sequencing method for the diagnosis of suspected ascitic infection in patients with liver cirrhosis in a clinical laboratory. Microbiol Spectr. 11:e02946-22."},{"key":"10.1016\/j.jceh.2025.103194_bib90","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/s13054-020-03367-7","article-title":"Point of care Aspergillus testing in intensive care patients","volume":"24","author":"Mercier","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jceh.2025.103194_bib91","article-title":"A point-of-care lateral flow assay can reliably diagnose invasive aspergillosis in hospitalized cirrhosis patients with acute decompensation","volume":"14","author":"Ralmilay","year":"2024","journal-title":"J Clin Exp Hepatol [Internet]"},{"key":"10.1016\/j.jceh.2025.103194_bib92","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jceh.2023.07.332","article-title":"Bedside Galactomannan Lateral Flow Assay (GM-LFA) for timely diagnosis of invasive pulmonary aspergillosis in ACLF patients","volume":"13","author":"Ralmilay","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib93","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1469-0691.2010.03274.x","article-title":"Matrix-assisted laser-desorption\/ionization biotyper: experience in the routine of a University hospital","volume":"17","author":"Bess\u00e8de","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jceh.2025.103194_bib94","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3390\/microorganisms10061188","article-title":"Spontaneous bacterial peritonitis: the incremental value of a fast and direct bacterial identification from ascitic fluids inoculated in blood culture bottles by MALDI-TOF MS for a better management of patients","volume":"10","author":"Lotte","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.jceh.2025.103194_bib95","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/liv.13095","article-title":"The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection","volume":"36","author":"Bruns","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103194_bib96","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/jhep.2002.33715","article-title":"Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites","volume":"36","author":"Such","year":"2002","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2025.103194_bib97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jhep.2007.08.012","article-title":"Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin","volume":"48","author":"Gonz\u00e1lez-Navajas","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib98","first-page":"2","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"key":"10.1016\/j.jceh.2025.103194_bib99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.coi.2014.10.009","article-title":"Self-DNA, STING-dependent signaling and the origins of autoinflammatory disease","volume":"31","author":"Ahn","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jceh.2025.103194_bib100","unstructured":"Apoptosis-derived Membrane Vesicles Drive the cGAS-STING Pathway and Enhance Type I IFN Production in Systemic Lupus Erythematosus [Internet]. [cited 2025 Mar 26]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29945921\/."},{"key":"10.1016\/j.jceh.2025.103194_bib101","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and coagulation: strangers or partners in crime?","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jceh.2025.103194_bib102","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jceh.2025.103194_bib103","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.redox.2015.01.008","article-title":"NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases","volume":"4","author":"Abderrazak","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.jceh.2025.103194_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.571810","article-title":"Reactive oxygen species interact with NLRP3 inflammasomes and are involved in the inflammation of sepsis: from mechanism to treatment of progression","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jceh.2025.103194_bib105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jceh.2025.103194_bib106","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through NALP3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jceh.2025.103194_bib107","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","article-title":"Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration","volume":"14","author":"P\u00e9trilli","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jceh.2025.103194_bib108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-immunol-032712-095944","article-title":"Recognition of bacteria by inflammasomes","volume":"31","author":"von Moltke","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jceh.2025.103194_bib109","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/ars.2011.4414","article-title":"Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy","volume":"16","author":"Gupta","year":"2012","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.jceh.2025.103194_bib110","doi-asserted-by":"crossref","first-page":"13279","DOI":"10.1021\/bi9828674","article-title":"Ca2+-induced increased lipid packing and domain formation in submitochondrial particles: a possible early step in the mechanism of Ca2+-stimulated generation of reactive oxygen species by the respiratory chain","volume":"38","author":"Grijalba","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.jceh.2025.103194_bib111","unstructured":"The Diverse Role of RIP Kinases in Necroptosis and Inflammation [Internet]. [cited 2025 Mar 26]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26086143\/."},{"key":"10.1016\/j.jceh.2025.103194_bib112","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Green. Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jceh.2025.103194_bib113","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","article-title":"Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group","volume":"271","author":"Fisher","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2025.103194_bib114","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/CCM.0000000000002749","article-title":"Mortality benefit of recombinant human Interleukin-1 receptor antagonist for sepsis varies by initial Interleukin-1 receptor antagonist plasma concentration","volume":"46","author":"Meyer","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib115","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","article-title":"Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The soluble TNF Receptor Sepsis Study Group","volume":"334","author":"Fisher","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jceh.2025.103194_bib116","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00003246-200103000-00006","article-title":"Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients","volume":"29","author":"Abraham","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib117","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2025.103194_bib118","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/CCM.0000000000000043","article-title":"Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-\u03b1 fragment antibody AZD9773 in adult patients with severe sepsis and\/or septic shock: randomized, double-blind, placebo-controlled phase IIb study","volume":"42","author":"Bernard","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib119","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial","volume":"25","author":"Opal","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib121","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood-2008-03-142760","article-title":"Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2025.103194_bib122","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/ATVBAHA.107.150631","article-title":"Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes","volume":"28","author":"Ito","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jceh.2025.103194_bib123","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1097\/CCM.0b013e3181a55184","article-title":"Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia","volume":"37","author":"Nagato","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5689","article-title":"ALK is a therapeutic target for lethal sepsis","volume":"9","author":"Zeng","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jceh.2025.103194_bib125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study","volume":"4","author":"Davenport","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jceh.2025.103194_bib126","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1164\/rccm.201602-0368OC","article-title":"Comparative analysis of the host response to community-acquired and hospital-acquired pneumonia in critically ill patients","volume":"194","author":"Vught","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib127","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1164\/rccm.201608-1685OC","article-title":"Shared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumonia","volume":"196","author":"Burnham","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib128","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1084\/jem.20111354","article-title":"A genomic storm in critically injured humans","volume":"208","author":"Xiao","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jceh.2025.103194_bib129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2213-2600(23)00468-X","article-title":"Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies","volume":"12","author":"Shankar-Hari","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jceh.2025.103194_bib130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4236\/ojneph.2021.112023","article-title":"Multiple-Organ extracorporeal support therapies in critically ill patients","volume":"11","author":"Daza","year":"2021","journal-title":"Open J Nephrol"},{"key":"10.1016\/j.jceh.2025.103194_bib131","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/TA.0b013e318248bc6c","article-title":"Effectiveness of short-term 6-hour high-volume hemofiltration during refractory severe septic shock","volume":"72","author":"Tapia","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jceh.2025.103194_bib132","doi-asserted-by":"crossref","first-page":"R294","DOI":"10.1186\/cc3529","article-title":"Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival","volume":"9","author":"Ratanarat","year":"2005","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.jceh.2025.103194_bib133","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib134","doi-asserted-by":"crossref","first-page":"e988","DOI":"10.1097\/CCM.0000000000003350","article-title":"A double-blind randomized controlled trial of high cutoff versus standard hemofiltration in critically ill patients with acute kidney injury","volume":"46","author":"Atan","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib135","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-Day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2025.103194_bib136","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000490694","article-title":"From multiple organ support therapy to extracorporeal organ support in critically ill patients","volume":"48","author":"Ronco","year":"2019","journal-title":"Blood Purif"},{"key":"10.1016\/j.jceh.2025.103194_bib137","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000505565","article-title":"Efficacy of HA330 hemoperfusion adsorbent in patients followed in the intensive care unit for septic shock and acute kidney injury and treated with continuous venovenous hemodiafiltration as renal replacement therapy","volume":"49","author":"K\u0131v\u0131lc\u0131m Ka\u00e7ar","year":"2020","journal-title":"Blood Purif"},{"key":"10.1016\/j.jceh.2025.103194_bib138","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/cc9411","article-title":"Clinical review: blood purification for sepsis","volume":"15","author":"Rimmel\u00e9","year":"2011","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.jceh.2025.103194_bib139","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13613-021-00905-6","article-title":"Can the cytokine adsorber CytoSorb\u00ae help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity-score matching analysis","volume":"11","author":"Scharf","year":"2021","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jceh.2025.103194_bib140","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1213\/00000539-198705000-00018","article-title":"Pulmonary dysfunction during one-lung ventilation caused by HLA-specific antibodies against leukocytes","volume":"66","author":"De Wolf","year":"1987","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jceh.2025.103194_bib141","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.3390\/jcm10132939","article-title":"First evaluation of a new dynamic scoring system intended to support prescription of adjuvant CytoSorb hemoadsorption therapy in patients with septic shock","volume":"10","author":"Kogelmann","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2025.103194_bib142","unstructured":"Cytokine Removal in Human Septic Shock: Where are We and Where are We Going? [Internet]. [cited 2025 Mar 31]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31089920\/."},{"key":"10.1016\/j.jceh.2025.103194_bib143","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000313773","article-title":"Blood purification in sepsis: a new paradigm","volume":"165","author":"Peng","year":"2010","journal-title":"Contrib Nephrol"},{"issue":"suppl 6","key":"10.1016\/j.jceh.2025.103194_bib144","first-page":"3","article-title":"The haemodialysis system: basic mechanisms of water and solute transport in extracorporeal renal replacement therapies","volume":"13","author":"Ronco","year":"1998","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.jceh.2025.103194_bib145","first-page":"35","article-title":"Early initiation of extracorporeal blood purification using the AN69ST (oXiris\u00ae) hemofilter as a treatment modality for COVID-19 patients: a single-centre case series","volume":"37","author":"Ugurov","year":"2022","journal-title":"Braz J Cardiovasc Surg"},{"key":"10.1016\/j.jceh.2025.103194_bib146","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2025.103194_bib147","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/hep.20195","article-title":"In vitro comparison of the molecular adsorbent recirculating system (MARS) and single-pass albumin dialysis (SPAD)","volume":"39","author":"Sauer","year":"2004","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2025.103194_bib148","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jhep.2023.03.013","article-title":"Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on-chronic liver failure","volume":"79","author":"Agarwal","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib149","unstructured":"Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study [Internet]. [cited 2025 Mar 31]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28589286\/."},{"key":"10.1016\/j.jceh.2025.103194_bib150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/cc4825","article-title":"The Molecular Adsorbent Recirculating System (MARS\u00ae) in the intensive care unit: a rescue therapy for patients with hepatic failure","volume":"10","author":"Saliba","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.jceh.2025.103194_bib151","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13054-017-1662-9","article-title":"Hemoadsorption by CytoSorb in septic patients: a case series","volume":"21","author":"Kogelmann","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.jceh.2025.103194_bib152","unstructured":"Hemoadsorption in the critically ill\u2014Final results of the International CytoSorb Registry [Internet]. [cited 2025 Apr 1]. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0274315."},{"key":"10.1016\/j.jceh.2025.103194_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5492\/wjccm.v9.i1.1","article-title":"Experience with hemoadsorption (CytoSorb\u00ae) in the management of septic shock patients","volume":"9","author":"Mehta","year":"2020","journal-title":"World J Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib154","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5492\/wjccm.v10.i1.22","article-title":"Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb\u00ae) in patients with sepsis and septic shock","volume":"10","author":"Paul","year":"2021","journal-title":"World J Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s13054-019-2588-1","article-title":"Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study","volume":"23","author":"Brouwer","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jceh.2025.103194_bib156","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0040-1708479","article-title":"Combined use of CytoSorb and ECMO in patients with severe pneumogenic sepsis","volume":"69","author":"Akil","year":"2021","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jceh.2025.103194_bib157","first-page":"3964","article-title":"Effect of high-volume hemofiltration in critically ill patients: a systematic review and meta-analysis","volume":"25","author":"Junhai","year":"2019","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"10.1016\/j.jceh.2025.103194_bib158","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-013-2967-z","article-title":"High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial","volume":"39","author":"Boyau","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib159","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/sdi.12963","article-title":"Continuous renal replacement therapy and extended indications","volume":"34","author":"Ronco","year":"2021","journal-title":"Semin Dial"},{"key":"10.1016\/j.jceh.2025.103194_bib160","first-page":"1060","article-title":"Management of acute renal replacement therapy in critically ill cirrhotic patients","volume":"15","author":"Zevallos","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jceh.2025.103194_bib161","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000501390","article-title":"Hyperammonemia, the last indication of high-volume hemodiafiltration in adult and children: a structured review","volume":"48","author":"Redant","year":"2019","journal-title":"Blood Purif"},{"key":"10.1016\/j.jceh.2025.103194_bib162","first-page":"491","article-title":"Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection","volume":"19","author":"Shum","year":"2013","journal-title":"Hong Kong Med J Xianggang Yi Xue Za Zhi"},{"key":"10.1016\/j.jceh.2025.103194_bib163","doi-asserted-by":"crossref","DOI":"10.1186\/cc13184","article-title":"High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis","volume":"18","author":"Clark","year":"2014","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.jceh.2025.103194_bib164","first-page":"595","article-title":"High-volume hemofiltration in critically ill patients: a systematic review and meta-analysis","volume":"80","author":"Lehner","year":"2014","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.jceh.2025.103194_bib165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000508810","article-title":"Similarities, differences, and potential synergies in the mechanism of action of albumin dialysis using the MARS albumin dialysis device and the CytoSorb hemoperfusion device in the treatment of liver failure","volume":"50","author":"Dominik","year":"2021","journal-title":"Blood Purif"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2025.103194_bib166","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S1665-2681(19)31602-3","article-title":"Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS)","volume":"10","author":"Mitzner","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2025.103194_bib167","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10353-005-0151-6","article-title":"Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study","volume":"37","author":"Faybik","year":"2005","journal-title":"Eur Surg"},{"key":"10.1016\/j.jceh.2025.103194_bib168","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/liv.15361","article-title":"APASL-ACLF Research Consortium\u2013Artificial Intelligence (AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patients","volume":"43","author":"Verma","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2025.103194_bib169","article-title":"Machine learning for the prediction of all-cause mortality in patients with sepsis-associated acute kidney injury during hospitalization","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2025.103194_bib170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/jcm14010286","article-title":"Artificial intelligence in sepsis management: an overview for clinicians","volume":"14","author":"Bignami","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jceh.2025.103194_bib171","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/CCM.0000000000003891","article-title":"A machine learning Algorithm to predict severe sepsis and septic shock: development, implementation, and impact on clinical practice","volume":"47","author":"Giannini","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2025.103194_bib172","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.compbiomed.2019.04.027","article-title":"Evaluation of a machine learning algorithm for up to 48-hour advance prediction of sepsis using six vital signs","volume":"109","author":"Barton","year":"2019","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.jceh.2025.103194_bib173","article-title":"Clinical factors associated with rapid treatment of sepsis","volume":"16","author":"Xing","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2025.103194_bib174","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bja.2020.11.039","article-title":"Machine learning methods to improve bedside fluid responsiveness prediction in severe sepsis or septic shock: an observational study","volume":"126","author":"Bataille","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jceh.2025.103194_bib175","unstructured":"Roy Adams, Katherine E Henry, Anirudh Sridharan, Hossein Soleimani, Andong Zhan N Rawat et al. Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis. Nat Med [Internet]. [cited 2025 Jan 14]."},{"key":"10.1016\/j.jceh.2025.103194_bib176","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11739-024-03535-5","article-title":"Real-time machine learning-assisted sepsis alert enhances the timeliness of antibiotic administration and diagnostic accuracy in emergency department patients with sepsis: a cluster-randomized trial","volume":"19","author":"Kijpaisalratana","year":"2024","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jceh.2025.103194_bib177","doi-asserted-by":"crossref","DOI":"10.1136\/bmjhci-2019-100109","article-title":"Effect of a sepsis prediction algorithm on patient mortality, length of stay and readmission: a prospective multicentre clinical outcomes evaluation of real-world patient data from US hospitals","volume":"27","author":"Burdick","year":"2020","journal-title":"BMJ Health Care Inform"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325006942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688325006942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T03:33:14Z","timestamp":1769225594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688325006942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":177,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0973688325006942"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103194","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future Management of Sepsis in Liver Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2025.103194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103194"}}